Shandong Weigao Group Medical Polymer Co Ltd
F:UK2

Watchlist Manager
Shandong Weigao Group Medical Polymer Co Ltd Logo
Shandong Weigao Group Medical Polymer Co Ltd
F:UK2
Watchlist
Price: 0.3585 EUR -11.31% Market Closed
Market Cap: €1.6B

Wall St Price Targets

UK2 Price Targets Summary
Shandong Weigao Group Medical Polymer Co Ltd

Wall Street analysts forecast UK2 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for UK2 is 1.1707 EUR with a low forecast of 0.7567 EUR and a high forecast of 1.5419 EUR.

Lowest Forecast
Price Target
0.7567 EUR
111% Upside
Average Forecast
Price Target
1.1707 EUR
227% Upside
Highest Forecast
Price Target
1.5419 EUR
330% Upside
Shandong Weigao Group Medical Polymer Co Ltd Competitors:
Price Targets
XLO
Xilio Therapeutics Inc
125% Upside

Revenue
Forecast

11% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
11% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 6%.

Gross Profit
Forecast

10% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
10% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 2 years is 15%.

Operating Income
Forecast

6% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
6% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 3 years is 9%.

Pre-Tax Income
Forecast

-4% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
-4% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been -4%. The projected CAGR for the next 3 years is 9%.

Net Income
Forecast

-6% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
-6% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 14 years, the compound annual growth rate for Net Income has been -6%. The projected CAGR for the next 3 years is 10%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is UK2's stock price target?
Price Target
1.1707 EUR

According to Wall Street analysts, the average 1-year price target for UK2 is 1.1707 EUR with a low forecast of 0.7567 EUR and a high forecast of 1.5419 EUR.

What is the Revenue forecast for Shandong Weigao Group Medical Polymer Co Ltd?
Projected CAGR
6%

Over the last 14 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 6%.

What is the Gross Profit forecast for Shandong Weigao Group Medical Polymer Co Ltd?
Projected CAGR
15%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 2 years is 15%.

What is the Operating Income forecast for Shandong Weigao Group Medical Polymer Co Ltd?
Projected CAGR
9%

Over the last 14 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 3 years is 9%.

What is the Pre-Tax Income forecast for Shandong Weigao Group Medical Polymer Co Ltd?
Projected CAGR
9%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been -4%. The projected CAGR for the next 3 years is 9%.

What is the Net Income forecast for Shandong Weigao Group Medical Polymer Co Ltd?
Projected CAGR
10%

Over the last 14 years, the compound annual growth rate for Net Income has been -6%. The projected CAGR for the next 3 years is 10%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett